List of Contents

Immune Health Supplements Market Size, Share, and Trends 2024 to 2034

The global immune health supplements market size is calculated at USD 23.14 billion in 2025 and is forecasted to reach around USD 43.80 billion by 2034, accelerating at a CAGR of 7.36% from 2025 to 2034. The North America immune health supplements market size surpassed USD 9.91 billion in 2024 and is expanding at a CAGR of 7.40% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 4309
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immune Health Supplements Market 

5.1. COVID-19 Landscape: Immune Health Supplements Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immune Health Supplements Market, By Product

8.1. Immune Health Supplements Market Revenue and Volume, by Product

8.1.1. Vitamin and Mineral Supplements

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Vitamin C Supplements

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Vitamin D Supplements

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Vitamin B complex Supplements

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Multivitamins

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Selenium Supplements

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Zinc Supplements

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Herbal Supplements

8.1.8.1. Market Revenue and Volume Forecast

8.1.9. Probiotic Supplements

8.1.9.1. Market Revenue and Volume Forecast

8.1.10. Others

8.1.10.1. Market Revenue and Volume Forecast

Chapter 9. Global Immune Health Supplements Market, By Form

9.1. Immune Health Supplements Market Revenue and Volume, by Form

9.1.1. Capsules

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Tablets

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Powder

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Liquid

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Gel

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Soft Gels

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Others

9.1.7.1. Market Revenue and Volume Forecast

Chapter 10. Global Immune Health Supplements Market, By Application 

10.1. Immune Health Supplements Market Revenue and Volume, by Application

10.1.1. Hair Growth

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Gut Health

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Respiratory Tract Infection

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Immune Health Supplements Market, By Mode of Medication

11.1. Immune Health Supplements Market Revenue and Volume, by Mode of Medication

11.1.1. Prescription Based

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Self-medication

11.1.2.1. Market Revenue and Volume Forecast

Chapter 12. Global Immune Health Supplements Market, By Distribution Channel

12.1. Immune Health Supplements Market Revenue and Volume, by Distribution Channel

12.1.1. Pharmacies/Drug Stores

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Supermarkets and Hypermarkets

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. E-commerce

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Immune Health Supplements Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product

13.1.2. Market Revenue and Volume Forecast, by Form

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by Mode of Medication

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product

13.1.6.2. Market Revenue and Volume Forecast, by Form

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by Mode of Medication

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product

13.1.7.2. Market Revenue and Volume Forecast, by Form

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by Mode of Medication

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product

13.2.2. Market Revenue and Volume Forecast, by Form

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by Mode of Medication  

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product

13.2.6.2. Market Revenue and Volume Forecast, by Form

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by Mode of Medication  

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product

13.2.9.2. Market Revenue and Volume Forecast, by Form

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by Mode of Medication

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product

13.2.12.2. Market Revenue and Volume Forecast, by Form

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by Mode of Medication

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product

13.2.14.2. Market Revenue and Volume Forecast, by Form

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by Mode of Medication

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product

13.3.2. Market Revenue and Volume Forecast, by Form

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by Mode of Medication

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product

13.3.6.2. Market Revenue and Volume Forecast, by Form

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by Mode of Medication

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product

13.3.8.2. Market Revenue and Volume Forecast, by Form

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by Mode of Medication

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product

13.3.10.2. Market Revenue and Volume Forecast, by Form

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by Mode of Medication

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product

13.3.11.2. Market Revenue and Volume Forecast, by Form

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by Mode of Medication

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product

13.4.2. Market Revenue and Volume Forecast, by Form

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by Mode of Medication

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product

13.4.6.2. Market Revenue and Volume Forecast, by Form

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by Mode of Medication

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product

13.4.8.2. Market Revenue and Volume Forecast, by Form

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by Mode of Medication

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product

13.4.10.2. Market Revenue and Volume Forecast, by Form

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by Mode of Medication

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product

13.4.11.2. Market Revenue and Volume Forecast, by Form

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by Mode of Medication

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product

13.5.2. Market Revenue and Volume Forecast, by Form

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by Mode of Medication

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product

13.5.6.2. Market Revenue and Volume Forecast, by Form

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by Mode of Medication

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product

13.5.8.2. Market Revenue and Volume Forecast, by Form

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by Mode of Medication

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Bayer AG

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Pfizer Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Sun Pharmaceutical Industries Limited

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Swisse Wellness Pty Ltd.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. GlaxoSmithKline Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abbott Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Amway Corp.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. The Nature's Bounty Co.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Herbalife Nutrition of America, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Himalaya Global Holdings Ltd.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global immune health supplements market size is expected to increase USD 43.80 billion by 2034 from USD 21.54 billion in 2024.

The global immune health supplements market will register growth rate of 7.36% between 2025 and 2034.

The major players operating in the immune health supplements market are Bayer AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Swisse Wellness Pty Ltd., GlaxoSmithKline Inc., Abbott Laboratories, Amway Corp., The Nature's Bounty Co., Herbalife Nutrition of America, Inc., Himalaya Global Holdings Ltd., American Health, Unilever, Sanofi, Novartis, Boehringer Ingelheim, Nestlè, Danone, and Others.

The driving factors of the immune health supplements market are the increasing emphasis on health and wellness and surge in demand for immune-boosting ingredients.

North America region will lead the global immune health supplements market during the forecast period 2025 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us